Sarepta Therapeutics
$7.22 B
๐Ÿ‡บ๐Ÿ‡ธ USA
Share price
Change (1 day)
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Market capitalization of Sarepta Therapeutics (SRPT)

Market cap: $7.22 Billion

As of September 2021 Sarepta Therapeutics has a market cap of $7.22 Billion. This makes Sarepta Therapeutics the world's 1957th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Sarepta Therapeutics from 2001 to 2021

Year Market cap Change
2021$6.28 B-53.3%
2020$13.45 B38.67%
2019$9.70 B25.09%
2018$7.75 B115.68%
2017$3.59 B140.16%
2016$1.49 B-14.94%
2015$1.76 B194.49%
2014$0.59 B-22.27%
2013$0.76 B-5.98%
2012$0.81 B708.83%
2011$0.10 B-57.54%
2010$0.23 B47.65%
2009$0.16 B244.53%
2008$0.04 B-48.47%
2007$0.09 B-46.27%
2006$0.16 B-4.22%
2005$0.17 B107.9%
2004$0.08 B-39.45%
2003$0.14 B5.62%
2002$0.13 B-47.63%
2001$0.25 B